Regulus, will present at the H.C. Wainwright Global Investment Conference
Well, it´s something anyhow. Maybe they will give a bit more info, but likely just the usual blurb.
SAN DIEGO, May 17, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that Jay Hagan, President and Chief Executive Officer of Regulus, will present at the H.C. Wainwright Global Investment Conference. An on-demand webcast presentation will be available on Tuesday, May 24, 2022, at 7:00 a.m. ET.
Regulus Therapeutics Inc. Logo
The on-demand webcast will be available under "Events and Presentations" through the investor relations section of the Company's website at www.regulusrx.com and will be archived for 90 days following the presentation date.
